SMMT
Summit Therapeutics PLC
16.70$
-1.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11,564.5% | +345.5% | +113.9% | +197.1% | -95.6% | +13.2% | +144.7% | +51.1% | +69.8% | -2.7% | +2.4% | -32.2% | +85.5% | +496.3% | +302.9% | -24.7% | -98.5% | +187.7% | -67.8% | -100.0% | – | – | |
| – | +9,190.4% | +145.5% | +43.4% | +441.2% | -99.8% | +40,132.8% | -81.3% | -56.2% | -50.9% | -73.6% | -100.0% | – | +21.0% | +58.4% | -74.5% | +700.6% | – | – | – | -18.5% | +632.0% | -99.3% | |
| – | 0.0% | +1,128.4% | +169.2% | -91.8% | +122.3% | -918.1% | – | +267.1% | +69.8% | -2.7% | +2.4% | -32.2% | +85.5% | +496.3% | +298.0% | -23.7% | -98.5% | +187.7% | -67.8% | -451.5% | – | – | |
| – | +985.2% | +263.1% | +216.0% | +164.9% | -51.9% | -50.1% | -39.1% | +37.4% | +53.6% | +39.7% | +57.6% | +61.8% | +12.4% | +52.9% | +69.3% | -20.1% | -0.6% | +119.1% | -49.6% | +958.4% | -70.9% | +306.0% | |
| – | +72.0% | +2,282.1% | -51.9% | +495.6% | -24.0% | -2.0% | -30.1% | -63.7% | +60.3% | +24.7% | +90.7% | +25.3% | +78.4% | +44.2% | +35.6% | -42.6% | +51.4% | +67.9% | -6.3% | +7.3% | +103.6% | +1,051.5% | |
| – | +1,224.4% | +545.6% | +167.8% | +161.3% | -25.7% | -81.0% | +6.8% | +16.8% | +40.3% | +32.2% | +65.1% | +53.2% | +25.9% | +46.9% | +29.2% | -175.8% | – | +122.6% | -31.6% | +694.2% | -62.3% | +506.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +181.2% | -572.7% | – | – | – | – | – | |
| – | +22,087.8% | -97.1% | 0.0% | +542.1% | +54.5% | -8.3% | -94.1% | -25.6% | +33,502.2% | -99.1% | +2,917.7% | -21.6% | +206.8% | +53.0% | -62.4% | -93.3% | +510.8% | +10.2% | +1,466.2% | +274.0% | -47.2% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -45.0% | -1,347.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -338.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -54.1% | -871.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +34.5% | -336.8% | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.